| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.1B | $0.1B | $0.1B | $0.0B | — | — | — | — |
| EPS (Basic) | $4.77 | $3.91 | $3.69 | $1.02 | $0.93 | $0.79 | $0.74 | $0.65 |
| EPS (Diluted) | $4.75 | $3.89 | $3.67 | $1.01 | $0.92 | $0.78 | $0.73 | $0.64 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.5B | $8.9B | $8.2B | $7.5B | $6.6B | $4.6B | $3.7B | $3.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | $0.2B | $0.2B |
| Total Liabilities | $8.5B | $7.9B | $7.3B | $6.7B | $6.0B | $4.2B | $3.3B | $2.9B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.1B | $0.9B | $0.9B | $0.8B | $0.7B | $0.4B | $0.4B | $0.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.1B | $-0.7B | $-0.4B | $-0.4B | $-0.1B | $-0.8B | $-0.2B | $-0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.5B | $0.6B | $0.4B | $-0.5B | $0.6B | $0.8B | $0.2B | $0.0B |